global glp-1 market size 2025 Receptor Agonist Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Agonists Weight Loss Drugs

6 Benefits of Combining Insulin and GLP-1 Drugs Key takeaways: Basal insulin and GLP-1 combinations like Xultophy and Soliqua help lower A1C with less risk of hypoglycemia

Indirect Cardiac Effects Gastrointestinal side effects, particularly severe nausea, vomiting, and diarrhea, can lead to dehydration and electrolyte disturbances (hypokalemia, hypomagnesemia) that may affect cardiac rhythm

One theory, he said, is that because the medications suppress appetite, some patients may not get enough key nutrients, such as vitamin D and calcium, which are important for maintaining bone health

However, modern diets, which often lack connective tissues and bone broths, frequently fall short of providing optimal levels of glycine

Keywords: glucagon-like peptide-1 receptor agonists, psychiatric adverse events, disproportionality analyses, FAERS database, pharmacovigilance study Introduction Diabetes has been one of the fastest growing public health issues worldwide in recent decades